Le Lézard
Classified in: Health
Subject: SVY

Global Mammography System Market, 2018-2028: Opportunities in the Rising Demand for Automated Image Analysis Techniques & Development of Low-cost Mammography Systems


DUBLIN, Jan 14, 2019 /PRNewswire/ --

The "Global Mammography System Market: Focus on Products, End Users, 15 Country Analysis, Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global mammography system market is anticipated to grow over $3.51 billion by 2028. The global mammography system market is projected to grow with a significant compound annual growth rate (CAGR) between the years 2018 and 2028, aided by the increasing prevalence of breast cancer across the globe.

Cancer imaging is consistently held to be one of the most important advances in the history of medical science and has become an integral part of the diagnosis and treatment of patients across the world. The cancer imaging industry requires constant advancements to provide simple, cost-effective, and efficient solutions for accurate diagnosis of the condition. The significant increase in the reimbursement policies across the globe consequentially promoted the development of cancer imaging industry. Further, the increasing demand for 3-D images by digital systems awareness about the early detection of cancer is significantly impacting the innovations by diagnostic imaging companies.

Moreover, a substantial increase in the prevalence of breast cancer has attracted more attention of investors for the mammography system market. Therefore, to sustain in the highly competitive market, the mammography systems are gradually becoming an advanced diagnostic tool for the diagnostic imaging industry with more benefits, including the development of 3-D images, simplicity, and cost-effectiveness. Further, current research environment demands efficient mammography systems with digital tomosynthesis systems to provide proper diagnosis of the disease, even with denser breast tissues. Besides reducing the turnaround time of treatment, the mammography system also provides magnification and light masking flexibility of 3-D images to physicians for more precise diagnosis. Furthermore, the mammography system market requires relaxation in the legal requirements and regulations to simplify the R&D as well as the approval process for the companies; thus, providing companies to devote more time to solve complex challenges by innovating new components or technologies to attain better product efficiency.

The contribution of North America to the global mammography system market was valued at approximately 37.95% in 2017. The different end users such as hospitals, ambulatory centres, and diagnostic centres are expected to progress at significant rates. Further, the substantial investments made by diagnostic imaging companies in the fields of mammography are promoting the development of breast cancer diagnosis are consequentially fuelling the growth of the North America mammography system market. However, Asia-Pacific is expected to grow at an impressive 7.37% CAGR during the forecast period. Moreover, the Asia-Pacific market contributed approximately 28.63% of the total global market value in 2017.

Research Highlights:

Key questions answered in the report:

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/dcmpp2/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets


These press releases may also interest you

18 jan 2019
The food recall warning issued on January 16, 2019, has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Golden City...

18 jan 2019
Innovaccer Inc., the leading San Francisco based healthcare data platform company, announced today that it has raised a total of $35 million capital in its Series B from Microsoft's venture fund M12, Westbridge, and Lightspeed. The additional...

18 jan 2019
Eli Lilly and Company announced that results from the global Phase 3 REACH-2 study of CYRAMZA® (ramucirumab) as a single agent in the second-line treatment of people with AFP-High (alpha-fetoprotein ?400 ng/mL) hepatocellular carcinoma (HCC) were...

18 jan 2019
Healthy Aging Medical Centers is pleased to announce it now offers Testosterone Replacement Therapy in New Jersey to help men and women get their testosterone levels back to optimal levels. How does one develop Low Testosterone? The combination of a...

18 jan 2019
The pharma industry recognizes the potential value of attacking complex diseases such as cancer through new therapies that utilize combinations of FDA-approved products. However, the path from design and development to filing and approval for these...

18 jan 2019
Aralez Pharmaceuticals Inc. (the "Company") announced today it has filed a current report on Form 8-K regarding certain organizational changes in connection with the winding down of its operations in connection with its bankruptcy proceedings. A copy...



News published on 14 january 2019 at 08:15 and distributed by: